Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Paclicad N Injection
Manufacturer/Marketed By : Cadila Pharmaceuticals Ltd
$77.91 $70.83
Sidmex Inovia offers bulk export supply of Paclicad N Injection (Albumin bound paclitaxel 100 mg) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.Documents,...
Albumin bound paclitaxel 100 mg
Active Pharmaceutical Ingredient
Paclicad N Injection
$77.91
$70.83
Sidmex Inovia offers bulk export supply of Paclicad N Injection (Albumin bound paclitaxel 100 mg) for hospitals, distributors and tender buyers. Request a quote with your quantity and destination country.
Documents, cold-chain shipping and tenders: see our Export FAQ.
Priority markets: United Arab Emirates, Brazil, Turkey, Singapore, Kenya, Somalia, Ghana, Saudi Arabia, Mauritius, Nigeria, Tanzania, Senegal, Democratic Republic of the Congo, Mali. We also export worldwide, including:
Middle East: Oman, Qatar, Kuwait, Bahrain, Iraq, Jordan, Lebanon, Yemen, Iran
Africa: Egypt, Algeria, Morocco, Libya, Burkina Faso, Côte d'Ivoire, Gambia, Rwanda, Ethiopia, Djibouti, South Africa, Zimbabwe
Asia: Sri Lanka, Bangladesh, Nepal, Maldives, Philippines, Vietnam, Laos, Malaysia, Thailand, Taiwan
CIS & Eastern Europe: Russia, Kazakhstan, Uzbekistan, Azerbaijan, Georgia, Serbia, Latvia, Tajikistan
Latin America & Caribbean: Mexico, Chile, Peru, Colombia, Bolivia, Venezuela
Europe & Other: Switzerland, United Kingdom, Canada
Related products we supply: Paclicad 260mg Injection
Paclicad N Injection is a potent microtubule inhibitor designed for the treatment of metastatic breast cancer, particularly in patients who have not responded to combination chemotherapy or have experienced a relapse within six months of adjuvant chemotherapy. Additionally, this injectable medication can be paired with carboplatin to provide first-line therapy for locally advanced or metastatic non-small cell lung cancer in individuals who are not candidates for radical surgical intervention or radiation treatment. Furthermore, Paclicad N 100mg is utilized in conjunction with gemcitabine as an initial treatment option for metastatic pancreatic cancer. While effective, it's crucial to be aware of potential side effects and contraindications, including severe allergic reactions and impacts on blood cell counts, which necessitate close monitoring during treatment. This medication represents a significant advancement in oncology, offering hope for patients facing challenging cancer diagnoses. Always consult with a healthcare provider before starting treatment to ensure that Paclicad N Injection is appropriate for your specific medical condition. With proper administration and oversight, Paclicad N can be an essential part of a comprehensive cancer treatment plan.
Active Pharmaceutical Ingredient
Uses
• Ovarian cancer
• Breast cancer
• Non-small cell lung cancer
• AIDS-related Kaposi’s sarcoma
Benefits
Paclicad N Injection binds to β-tubulin subunits of microtubules, interferes with interphase (a process involving cell growth) and mitotic functions (a process of cell division), and prevents the growth of cancer cells.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Most Common Side Effects
• Anemia, feeling tired
• Hair loss
• Burning, tingling, or numbness in your feet or hands
• Muscle and joint pain
• Vomiting, nausea
• Mouth or lip sores
• Infections
• Swelling of hands, feet, and face
• Bleeding
• Irritation at the injection site
• Low blood pressure
Common Side Effects
• Serious allergic reactions (rash, swelling of face, lips, throat, or tongue, trouble breathing, and swallowing)
• Severe diarrhea
• Severe stomach pain
How To Use
It will be given to you by a doctor or nurse. Do not self-administer. Your doctor will decide the dose and dosage of the Paclicad N Injection.
Safety Advice
• Breast Feeding: Stop breastfeeding during the treatment with Paclicad N Injection. Consult your doctor for potential risks.
• Alcohol: It is unsafe to consume alcohol with Paclicad N Injection.
• Liver: It is contraindicated in patients with severe liver disorders. Inform your doctor if you have any liver disorders before taking Paclicad N Injection.
• Lungs: It is unknown whether Paclicad N Injection can be given to patients with lung disorders. Please consult your physician for more advice.
• Driving: The alcohol present in Paclicad N Injection may affect your ability to drive. Avoid driving if you feel unwell.
• Pregnancy: Paclicad N Injection can harm your unborn baby. Tell your doctor if you are pregnant or planning to get pregnant before taking this injection.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.